NCT03000816View on ClinicalTrials.gov

A Study of SBRT for OligoMetastatic ESCC

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2020

Conditions
Esophageal Squamous Cell Carcinoma Metastatic
Interventions
RADIATION

SBRT

Patients with 1-4 metastases located in less than 2 organs/ lymphatic drainage regions that are 5 cm or less from each other and simultaneously treated with SBRT.

Trial Locations (1)

200032

Fudan Universtiy Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03000816 - A Study of SBRT for OligoMetastatic ESCC | Biotech Hunter | Biotech Hunter